亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Disease-free survival as a surrogate endpoint for overall survival in adults with resectable esophageal or gastroesophageal junction cancer: A correlation meta-analysis

置信区间 医学 危险系数 内科学 荟萃分析 二元分析 分布式文件系统 肿瘤科 比例危险模型 临床试验 代理终结点 食管癌 佐剂 临床终点 相关性 癌症 统计 数学 几何学 计算机安全 计算机科学
作者
Jaffer A. Ajani,Lisa W M Leung,Prianka Singh,Murat Kurt,In-Kyu Kim,Mir-Masoud Pourrahmat,Steve Kanters
出处
期刊:European Journal of Cancer [Elsevier BV]
卷期号:170: 119-130 被引量:2
标识
DOI:10.1016/j.ejca.2022.04.027
摘要

To evaluate disease-free survival (DFS) as a surrogate endpoint for overall survival (OS) using aggregate-level data from resectable esophageal or gastroesophageal junction cancer (EC/GEJC) trials assessing therapies in (neo)adjuvant and perioperative settings.A systematic literature review was conducted to identify trials reporting OS and DFS, or compatible progression-free survival (PFS). Bivariate random-effects meta-analysis was used to estimate correlation between the treatment effects on DFS/PFS and OS, and weighted linear regression models assuming trial sample sizes as weights were used to estimate surrogacy equations. The primary analysis consisted of trials across all treatment settings, and secondary analysis consisted of trials only in the adjuvant setting. Leave-one-out cross-validation (LOOCV) was performed to measure the stability and predictive accuracy of the surrogacy equations while surrogate threshold effects (STE)-the minimum treatment effect on DFS/PFS that would translate into a positive OS benefit-were derived to measure their usefulness.The primary analysis included 26 trials. The estimated correlation coefficient between the hazard ratio (HR) of DFS/PFS (HRDFS/PFS) and HR of OS (HROS) was 0.83 (95% confidence interval [CI]: 0.70-0.90). The estimated surrogacy equation was log(HROS) = 0.80 × log(HRDFS/PFS) with a corresponding STE of 0.82. Reported HROS was within the 95% prediction interval of the predicted HROS from the model for more than 95% of the trials in the LOOCV, indicating a valid model. Secondary analysis included 7 trials with an estimated correlation coefficient of 0.76 (95% CI: 0.18-0.95). Through LOOCV, the surrogacy equation in the adjuvant setting was deemed valid.Our meta-analysis suggests that HRDFS/PFS -where DFS/PFS is defined as time from resection to disease recurrence (local, locoregional, or distant) or death-is correlated to HROS, and a valid and useful surrogate predictor for HROS in the neoadjuvant, perioperative, or adjuvant settings.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
称心的寻桃完成签到 ,获得积分10
1秒前
4秒前
Ppop发布了新的文献求助30
4秒前
Laluna的应助被suicone采纳,获得10
4秒前
李健的小迷弟的应助被hdse采纳,获得10
5秒前
5秒前
6秒前
8秒前
9秒前
巨型肥猫完成签到,获得积分10
9秒前
LYZSh发布了新的文献求助10
10秒前
大个的应助被行走的鱼采纳,获得10
10秒前
vivi完成签到 ,获得积分10
13秒前
13秒前
毒药完成签到 ,获得积分10
17秒前
17秒前
宁静的夏天给站走跑的求助进行了留言
17秒前
霸气擎宇完成签到,获得积分10
18秒前
18秒前
美琦发布了新的文献求助10
18秒前
Ppop完成签到,获得积分10
19秒前
打打的应助被科研通管家采纳,获得10
20秒前
SciGPT的应助被科研通管家采纳,获得10
20秒前
充电宝的应助被科研通管家采纳,获得10
21秒前
vnewgnl的应助被科研通管家采纳,获得20
21秒前
清秀的冰兰完成签到 ,获得积分10
21秒前
myf发布了新的文献求助30
23秒前
浩然山河完成签到,获得积分10
24秒前
端庄的煎蛋完成签到,获得积分10
24秒前
BIBIYU完成签到,获得积分10
25秒前
阿腾发布了新的文献求助10
25秒前
小巧的孤丹完成签到,获得积分10
26秒前
美琦完成签到,获得积分10
28秒前
霸气猕猴桃完成签到 ,获得积分10
30秒前
31秒前
LYZSh完成签到,获得积分10
33秒前
Nobodyet完成签到,获得积分10
37秒前
宁缺毋滥完成签到,获得积分10
37秒前
卢茵完成签到,获得积分10
39秒前
钉钉完成签到,获得积分10
40秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179656
求助须知:如何正确求助?哪些是违规求助? 9569921
关于积分的说明 21807706
捐赠科研通 7775141
什么是DOI,文献DOI怎么找? 3433072
关于科研通互助平台的介绍 2557032
邀请新用户注册赠送积分活动 2478778